Telix Pharmaceuticals (innovations) Pty Ltd

This study tested a new drug (177Lu-DOTA-rosopatamab) that delivers radiation directly to prostate cancer cells. It was for men with advanced prostate cancer that had stopped responding to hormone therapy. The trial aimed to see if adding this drug to standard care could slow can…